Katherine Williams

11PUBLICATIONS
81CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 06, 2026
Loss of the autoimmune risk gene TREX1 reveals a convergence of mechanisms promoting immune tolerance loss and antitumor immunity.

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Nov 17, 2025
Fibroblastic FLT3L supports lymph node dendritic cells in the interfollicular niche.

Sunny Z Wu, Ryan S Lane, Christopher Davidson

|Feb 05, 2025
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour control.

Béatrice Bréart, Katherine Williams, Stellanie Krimm

|Jan 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Katherine Nutsch, Karl L Banta, Thomas D Wu

|Dec 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation.

Katherine Nutsch, Karl L Banta, Thomas D Wu

Pageof 2

Frequent Collaborators

7 joint publications

Sören Müller

4 joint publications

Ira Mellman

3 joint publications

Barzin Y Nabet

3 joint publications

Nathaniel R West